Table 1 Patient characteristics at study inclusion
Characteristics | Data |
|---|---|
Age, yr | |
Median (IQR) | 56 [50–64] |
Minimum/maximum | 25/75 |
Male sex, n (%) | 18 (56.3) |
Outcome, n (%) | |
ICU survival | 12 (37.5) |
Hospital survival | 11 (34.4) |
Scores at study inclusion, mean ± SD | |
APACHE II | 21 ± 6.8 |
SAPS II | 54 ± 16.6 |
SOFA | 13 ± 4.4 |
Renal function on study inclusion, n (%) | |
AKIN stage | |
1 | 3 (9.4) |
2 | 11 (34.4) |
3 | 18 (56.3) |
Haemodialysis before study inclusion | 19 (59.4) |
Liver failure, n (%) | |
Acute-on-chronic | 18 (56.3) |
Acute | 9 (28.1) |
Liver graft failure | 5 (15.6) |